Endometrial cancer (EC) is the most prevalent gynecologic malignancy in Japan. Atypical endometrial hyperplasia (AEH) is viewed as the premalignant lesion of EC, however it is often difficult to distinguish EC from AEH. The rate of concurrent EC in women diagnosed preoperatively with AEH based on endometrial biopsy was reported as 17-52%. Although hysteroscopic inspection and total curettage are considered as useful methods to make diagnosis of endometrial lesions, there is no report using this combined method to discriminate EC from AEH. The purpose of this study was to examine whether hysteroscopic inspection and total curettage improve the prevalence of EC among women diagnosed preoperatively with AEH. We reviewed 22 patients who underwent hysteroscopic inspection and total curettage and were diagnosed with AEH before undergoing hysterectomy between November 2001 and May 2011. The diagnosis made with the hysterectomy specimens revealed AEH in 10 patients (45.5%), endometrial hyperplasia without atypia in 3 (13.6%), and endometrioid adenocarcinoma, the most common type of EC, in 9 (40.9%). Endometrioid adenocarcinoma included 7 patients without myometrial invasion (31.8%) and 2 patients with superficial myometrial invasion (9.1%). There was no hysteroscopic finding that was specific for EC or AEH. In conclusion, about 41% of women who underwent hysterectomy under a diagnosis of AEH were found to have coexisting adenocarcinoma, although the prevalence of EC among those women was similar to that in earlier reports with endometrial biopsy. Accordingly, we must be careful in planning the therapeutic strategy for women with a preoperative diagnosis of AEH.
Endometrial cancer (EC) is the most common gynecologic malignancy in Europe and the United States. EC has also increased in Japan in the last 20 years, and in 2009 moved ahead of cervical cancer as the most prevalent malignant gynecologic disease in Japan . Endometrioid adenocarcinoma is the most common pathologic type of EC, and adenomatous hyperplasia was shown to be a premalignant lesion of endometrioid adenocarcinoma 50 years ago (Gusberg and Kaplan 1963) . Currently, endometrial hyperplasia, atypical endometrial hyperplasia (AEH) and well-differentiated endometrioid adenocarcinoma are viewed as a continuous spectrum of the disease. Kurman et al. (1985) classified hyperplasia as simple hyperplasia without atypia, complex hyperplasia without atypia, simple atypical hyperplasia, and complex atypical hyperplasia with cellular atypia and architectural atypia. They found that the rates of progression to EC from simple hyperplasia without atypia, complex hyperplasia without atypia, simple atypical hyperplasia and complex atypical hyperplasia were 1%, 3%, 8% and 29%, respectively (Kurman et al. 1985) . The World Health Organization (WHO) and the International Society of Gynecologic Pathologists (ISGP) now use this classification.
In patients diagnosed as AEH with endometrial biopsy, the reported rate of concurrent endometrial adenocarcinoma in hysterectomy specimens is 17-52% (Kurman and Norris 1982; Dunton et al. 1996) . The prevalence of EC with myometrial invasion was also reported as 8-39% (Kurman and Norris 1982; Merisio et al. 2005) . Because of the high rate of concomitant cancer, even if endometrial atypical hyperplasia is diagnosed with endometrial biopsy, complete endometrial curettage is recommended in the Japan Society of Gynecologic Oncology guidelines for treatment of uterine body neoplasms (Nagase et al. 2010) . However, only a few studies examined endometrial adenocarcinoma in hysterectomy specimens after diagnosis of AEH with total curettage (Shutter and Wright 2005; Merisio et al. 2005; Trimble et al. 2006) , and there is no report using hysteroscopic inspection and total curettage preoperatively. The purpose of this study was to examine whether hysteroscopic inspection and total curettage are sufficient for diagnosing AEH. In this study, we reviewed the pathological diagnosis of hysterectomy specimens in women diagnosed as AEH with hysteroscopic inspection and total curettage. The primary endpoint was the prevalence of endometrial adenocarcinoma. Secondary endpoints were the rate of myometrial invasion and the grade of endometrioid adenocarcinoma.
Patients and Methods
The subjects were 22 patients who were diagnosed with AEH based on hysteroscopic inspection and total curettage, and then underwent total hysterectomy between November 2001 and May 2011 in the Department of Gynecology, Tohoku University Hospital. The indications for hysteroscopic inspection and total curettage in our institute were women diagnosed with AEH by endometrial biopsy; referred with a diagnosis of AEH; clinically suspected to have AEH or endometrial cancer by endometrial cytology or imaging studies, although these diagnoses were not made with endometrial biopsy; or under treatment with medroxyprogesterone acetate (MPA) therapy for AEH or early stage EC. Patients treated with MPA to preserve fertility were excluded from the study.
Hysteroscopic inspection and total curettage were performed in three steps under intravenous anesthesia as a day case admission: 1) insertion of a flexible scope into the uterine cavity for filling with isotonic sodium chloride as a distension medium, and inspection for the presence of an elevated lesion, atypical vessel or necrotic tissue; 2) thorough curettage of the uterine cavity with particular attention to endometrial lesions; and 3) reinsertion of a hysteroscope to ensure that all endometrial lesions had been removed. Clinical information and hysteroscopic findings were obtained from medical records. The primary doctor made a pathological diagnosis and two other doctors reviewed this decision and established the final diagnosis. A pathological diagnosis of non-atypical hyperplasia in the hysterectomy specimen was regarded as AEH.
Results
Of the 22 patients, the diagnoses made with the hysterectomy specimens were AEH in ten patients (45.5%), endometrial hyperplasia without atypia in three patients (13.6%), and endometrioid adenocarcinoma in nine patients (40.9%). The AEH patients included two patients with simple atypical hyperplasia and eight patients with complex atypical hyperplasia. The three patients diagnosed with endometrial hyperplasia without atypia showed complex hyperplasia without atypia. Endometrioid adenocarcinoma included seven grade 1 (G1) patients without myometrial invasion, one G1 patient with superficial myometrial invasion, and one grade 2 (G2) patient with superficial myometrial invasion, giving a total of seven patients (31.8%) without myometrial invasion and two patients (9.1%) with superficial myometrial invasion (Table 1) . Total hysterectomy with bilateral salpingo-oophorectomy was performed in 21 patients, and total hysterectomy with preservation of the ovaries was performed in one patient diagnosed with AEH based on the hysterectomy specimen. No patient has shown recurrence up to May 2012.
Comparison of the patients with endometrioid adenocarcinoma (EC group, n = 9) and all other patients (AEH group, n = 13) showed no significant differences in age, menstrual status, parity, body mass index (BMI), symptoms, thickness of the endometrium measured by trans-vaginal ultrasonography, and time from diagnosis to hysterectomy (Table 2) .
Hysteroscopic findings of an elevated lesion, atypical vessel or necrosis also did not differ significantly between the two groups (Table 3) . MRI information was available Table 1 . Diagnosis based on the hysterectomy specimen.
Diagnosis from hysterectomy
No. of patients (%)
Non-atypical endometrial hyperplasia 3 13.6
Simple hyperplasia 0
Complex hyperplasia 3 Atypical endometrial hyperplasia (AEH) 10 45.5
Simple atypical hyperplasia 2
Complex atypical hyperplasia 8
Endometrial carcinoma (EC) 9 40.9
Endometrioid adenocarcinoma 1a Grade1 7
Endometrioid adenocarcinoma 1b Grade1 1
Endometrioid adenocarcinoma 1b Grade2 1
Total 22 for eight patients in the EC group and 11 patients in the AEH group (Table 4 ). The exceptions were two patients in the AEH group and one patient with superficial myometrial invasion in the EC group. Abnormal endometrial signals (heterogenous intensity or intermediate to low intensity) were observed in 50% of EC patients and 45% of AEH patients. In the grade 1 patient with superficial myometrial invasion, the junctional zone was intact. The association between laceration of the junctional zone and myometrial invasion was unclear, and two EC patients and three AEH patients were incorrectly judged to have laceration of the junctional zone. MRI findings were similar between the two groups. We also analyzed whether hysteroscopic findings were concordant with MRI findings in patients who underwent MRI (n = 19). Endometrial elevated lesions were detected in eight patients (42%) by both hysteroscopy and MRI, in four patients (21%) by hysteroscopic inspection, and in one patient (5%) by MRI, whereas they were not detected by either method in 6 patients (32%) (data not shown).
Discussion
In this retrospective study, 41% of women who underwent hysterectomy under a diagnosis of AEH were found to have coexisting endometrial adenocarcinoma. These results are similar to those in previous reports (Table 5) (Kurman and Norris 1982; Janicek and Rosenshein 1994; Lambert et al. 1994; Hunter et al. 1994; Liapis et al. 1994; Widra et al. 1995; Dunton et al. 1996; Xie et al. 2002; Agostini et al. 2002; Kimura et al. 2003; Bilgin et al. 2004; Shutter and Wright 2005; Merisio et al. 2005; Garuti et al. 2006; Trimble et al. 2006; Dordević et al. 2007 ). Sampling errors Values are shown as a mean (± s.d.) or the number of patients (%). EC, endometrial cancer; AEH, atypical endometrial hyperplasia; BMI, body mass index. Values are shown as the number of patients (%). a Multiple findings were possible; therefore the totals are greater than 100%. EC, endometrial cancer; AEH, atypical endometrial hyperplasia. may account for the failure of diagnosis of EC. In one EC patient, a submucosal myoma might have prevented adequate sampling. In six EC patients, elevated lesions were found in hysteroscopy, and we checked whether these lesions were removed after total curettage; however, focal malignant lesions might not have been removed. Epstein et al. (2001) reported that in 87% of women with an endometrium > 5 mm and focal lesions in the uterine cavity, all or a part of the lesion remained in situ after dilatation and curettage. Thus, complete removal of an endometrial lesion is difficult even with total curettage. In the other two EC patients, hysteroscopy showed only atrophic endometrium, and it was unclear whether all of the lesions had been removed. For an occult lesion, diagnostic procedures in addition to conventional hysteroscopy are required. Narrow band imaging (NBI) is a new endoscopic technique for better visualization of mucosal microstructures and capillary structures, and may be promising for diagnosis of gastrointestinal lesions. Surico et al. (2009) first reported that NBI could be a useful methodology for early detection of endometrial lesions. Kisu et al. (2011) found that the sensitivity of diagnosis of AEH or EC was significantly higher using white light + NBI compared to white light only, without a decline in the specificity of diagnosis. In a large-scale multicenter study, Tinelli et al. (2011) found that NBI significantly improved the sensitivity (60% vs. 20%, P < 0.005) and positive predictive value (67% vs. 25%, P < 0.001) compared with white light only for diagnosis of high-risk hyperplasia, with no differences in specificity, negative predictive value, and accuracy. These reports indicate that NBI may be a useful procedure to complement a hysteroscopic examination, and NBI may become established in standard clinical practice in the near future.
In our institute, three doctors participate in pathological diagnosis for each patient to avoid misdiagnosis. Therefore, we believe that the diagnosis made is valid. In 2006, the GOG study found EC in hysterectomy specimens in 14 of 74 patients (18.9%) with a study panel consensus diagnosis of "less than AEH", and in 54 of 84 patients (64.3%) with a consensus diagnosis of carcinoma (Trimble et al. 2006) . However, the prevalence of EC among women diagnosed with AEH by study panel review was also relatively high (39.1%), which suggests that improvement of diagnostic accuracy for EC may be difficult based only on pathological diagnosis.
During a hysteroscopic examination, cancer cell dissemination into the peritoneal cavity may occur due to the pressure of the medium used for distention of the uterine cavity. In the present study, information on peritoneal cytology was available for 11 patients in the AEH group and all patients in the EC group. Peritoneal cytology was negative in all patients in the AEH group, and there was only one patient that was suspicious and no patients that were positive in the EC group. We used isotonic sodium chloride to inflate the uterine cavity, without use of a device to apply pressure. Chang et al. (2011) conducted a metaanalysis of the effect of hysteroscopy on peritoneal dissemi- nation of endometrial cancer cells. The risk was significantly associated with the use of a liquid medium for uterine cavity distention, but not with early-stage disease, although hysteroscopic examination in patients with endometrial cancer may increase the risk of dissemination of malignant cells into the peritoneal cavity. In addition, there was no evidence to support an association between preoperative hysteroscopic examination and a worse prognosis. Thus, Chang et al. (2011) concluded there is no reason to avoid diagnostic hysteroscopy before surgery in patients with endometrial cancer, especially in the early stage.
An endometrial lesion was not detected with MRI in more than half of our patients in both the EC and AEH groups. Thus, the utility of MRI for detection of myometrial invasion was unclear in this study, but T2WI has been shown to be useful for evaluation of myometrial invasion (Messiou et al. 2006 ). Dynamic imaging is useful for detection of myometrial invasion when the junctional zone is unclear because of age, myoma uteri, adenomyosis uteri, and deformity of the uterus (Messiou et al. 2006) . Thus, MRI is useful for detection of deep myometrial invasion, but it is difficult to distinguish early stage EC from AEH in an endometrial lesion detected by MRI. To our knowledge, differentiation of these lesions has not been achieved, although the apparent diffusion coefficient (ADC) is effective for distinguishing EC from normal endometrium or a benign endometrial lesion (Tamai et al. 2007; Takeuchi et al. 2009 ). Use of this parameter for distinguishing early EC from AEH requires further examination.
A summary of previous reports of the prevalence of endometrial cancer among women with a preoperative diagnosis of AEH is shown in Table 5 . Total curettage is generally viewed as superior to biopsy, but the available data do not clearly show the superiority of either technique, partly because several reports do not describe the method of preoperative diagnosis with clarity: for example, curetting may indicate biopsy or total curettage. In the 2006 large-scale prospective GOG study, the prevalences of endometrial adenocarcinoma among women diagnosed by dilatation and curettage (D and C) and by biopsy were 26% and 52%, respectively (Trimble et al. 2006) . These results show a surprisingly high prevalence of EC among women with a preoperative diagnosis of AEH, but they are supported by reports of similar prevalences of EC after diagnosis of AEH by D and C (Janicek and Rosenshein 1994; Dunton et al. 1996; Shutter and Wright 2005; Merisio et al. 2005; Trimble et al. 2006) (Table 5) . In this study, we also found a similar prevalence of endometrial adenocarcinoma, even after diagnosis of AEH with hysteroscopic inspection and total curettage. Thus, even with the combined use of these methods, it is difficult to detect localized EC. This is an important consideration in planning a therapeutic strategy for women with a preoperative diagnosis of AEH.
In the current study, the percentage of patients with myometrial invasion was lower than that in other studies (Table 5 ). To the best of our knowledge, the rates of myometrial invasion in women diagnosed with endometrial biopsy or total curettage have not been compared. A tumor with myometrial invasion is likely to expand on the endometrial surface and becomes easier to be detected with hysteroscopy and biopsy. Therefore, hysteroscopic inspection and total curettage might improve the accuracy of diagnosis of advanced endometrial adenocarcinoma, especially in patients with myometrial invasion. This hypothesis requires validation through further accumulation of patients.
